Olive S. Eckstein, MD
- Cancer and Blood Disorders
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Get to know Olive S. Eckstein, MD
Personal Statement
Dr. Olive Eckstein is a clinical expert with extensive experience in the evaluation and care of pediatric and adult patients with histiocytic disorders, lymphomas, and rare lymphoproliferative and immune disorders.
As a physician in one of the largest Histiocytosis and Lymphoma programs in the United States, Dr. Eckstein consults on patients from across the nation and around the world. She works with other pediatric subspecialists in the departments of Critical Care, Rheumatology, Immunology, and Infectious Disease at Texas Children's Hospital to improve our understanding of the biologic and genetic mechanisms of this disease, as well as to enroll patients on clinical trials targeting these mechanisms.
Dr. Eckstein is the Study Chair of LCH REASON, a Phase 3, multi-site clinical trial for upfront treatment of Langerhans Cell Histiocytosis (LCH); the Study Vice-Chair of NACHO-Cobimetinib, a Phase 2, multi-site clinical trial for histiocytic disorders; and Vice-Chair of APEC1621E, a Phase 2 subprotocol of the Children's Oncology Group (COG) Pediatric MATCH trial.
She has also been involved with multiple investigative clinical trials and critically analyzes historical clinical and biologic data for patients with hemophagocytic lymphohistiocytosis, histiocytic disorders, and pediatric lymphomas.
Dr. Olive Eckstein received her medical degree from the Chicago Medical School at Rosalind Franklin University of Medicine and Science and completed her residency in pediatrics at Children's Hospital Boston. Following residency, Dr. Eckstein worked as a hospitalist in the Bone Marrow Transplant Department at Cincinnati Children's Hospital Medical Center.
She has been an avid volunteer for the last decade after serving in AmeriCorps and is fluent in American Sign Language.
The patients and families she cares for inspire Dr. Eckstein every day with their strength and resilience. She is committed to supporting and guiding them through this challenging time by educating and empowering patients and families with the most up-to-date information, listening with empathy and compassion, and providing hope for the future.
She is board certified by the American Board of Pediatrics in both pediatrics and pediatric hematology-oncology.
Clinical Interests
- Langerhans Cell Histiocytosis (LCH)
- Neurodegenerative LCH (LCH-ND_
- Central Nervous System LCH (CNS-LCH)
- Hemophagocytic Lymphohistiocytosis (HLH)
- Juvenile Xanthogranuloma (JXG)
- Rosai-Dorfman Disease (RDD)
- Pediatric Lymphomas (Hodgkin and Non-Hodgkin)
- Lymphoproliferative and immune disorders (including ALPS)
- Post-transplant Lymphoproliferative Disease (PTLD)
- Chronic Active EBV (CAEBV)
- Bone Marrow (Stem Cell) Transplant for Hemophagocytic Lymphohistiocytosis (HLH) and Lymphoproliferative Disorders
Education
,
,
,
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society of Clinical Oncology (ASCO) | Member |
| American Society for Pediatric Hematology Oncology (ASPHO) | Member |
| American Society for Hematology (ASH) | Member |
| Children's Oncology Group (COG) | Member |
| Histiocyte Society | Member |
| North American Consortium for Histiocytosis (NACHO) | Member |
Board Certifications
American Board of Pediatrics
American Board of Pediatrics - Pediatric Hematology/Oncology
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.